利用形状选和分子动力学模拟来优化PARP1-特定的化疗/无线电增强剂,用于抗瘤药物设计
Hifza Khizer1, Arooma Maryam2, Adnan Ansari1
1National Center for Bioinformatics, Quaid-i-Azam University, Islamabad, Pakistan.
Archives of biochemistry and biophysics
|April 20, 2024
概括
研究人员确定了具有高选择性的新型PARP1抑制剂,这对于开发向癌症疗法至关重要. 这一发现有助于制造专门针对PARP1的药物,最大限度地减少与抑制PARP2和PARP3相关的副作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 聚 (ADP-ribose) 聚合酶1 (PARP1) 对于通过基切除途径进行DNA修复至关重要.
- 在具有BRCA突变的癌症中,PARP1是关键的治疗标.
- 同时抑制PARP1,PARP2和PARP3可以破坏细胞功能和免疫反应.
研究的目的:
- 发现具有对PARP1.1增强选择性的新型PARP抑制剂.
- 了解驱动PARP1特异性的分子相互作用.
主要方法:
- 使用基于形状的选,选了5.93亿种化合物.
- 采用了等级对接,MMGBSA,分子动力学 (MD) 模拟和键频率分析.
- 利用了施罗丁格套件进行计算分析.
主要成果:
- 已识别出特定的化合物 (例如,ZINC001258189808,ZINC000092332196),它们对PARP1.1具有很高的亲和力.
- 特定的关键活性部位残留物 (H862,G863,R878,M890,Y896,F897) 对于PARP1特定结合至关重要.
- 观察到与PARP2和PARP3的差异相互作用,证实了PARP1的选择性.
结论:
- 这项研究促进了对PARP1特异性抑制剂的理解.
- 确定了具有针对性癌症治疗潜力的新型化合物.
- 计算方法促进了选择性PARP1抑制剂的开发.
相关概念视频
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


